ACTIVE

PHARM-OZ

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

85,6 k €

-18.7% YoY

Gross margin

310,7 k €

-1.7% YoY

Equity

343 k €

+3.2% YoY

Workforce

2,3 ETP

0.0% YoY

What does PHARM-OZ do?

PHARM-OZ is a Public limited company incorporated in 1968. Its registered office is in Charleroi. It employs on average 2,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0401.670.169

Incorporation

01/01/1968

Legal form

Public limited company

Registered office

Chaussée de Châtelet 40
6060 Charleroi · Wallonie

Contributed capital

61 500,00 €

Latest accounts

31/12/2025

Average workforce

2,3 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	310,7 k €	-1.7%	316,2 k €	+16.0%	272,5 k €	+32.3%	206 k €	+2.6%	200,7 k €	-54.1%	437,5 k €	+1.1%	433 k €	-5.7%	459 k €	-3.5%	475,8 k €	+15.3%	412,7 k €	+16.3%	355 k €	-0.1%	355,3 k €	+11.4%	319,1 k €	+0.8%	316,5 k €	+5.8%	299 k €	-19.1%	369,8 k €	+24.3%	297,4 k €	+20.6%	246,7 k €
EBITDA	152,4 k €	-2.0%	155,5 k €	+32.3%	117,5 k €	+858%	12,3 k €	-65.4%	35,5 k €	-80.0%	177 k €	-12.7%	202,7 k €	-17.9%	246,8 k €	+24.2%	198,8 k €	-8.1%	216,3 k €	+21.8%	177,6 k €	-11.5%	200,7 k €	+11.7%	179,7 k €	+7.7%	166,8 k €	+3.6%	161,1 k €	-36.7%	254,6 k €	+26.7%	200,9 k €	+54.1%	130,4 k €
Operating result	101,4 k €	-19.4%	125,9 k €	+21.3%	103,7 k €	+3267%	3,1 k €	-85.9%	21,8 k €	-74.4%	84,9 k €	-19.6%	105,7 k €	-0.2%	105,9 k €	+90.4%	55,6 k €	+58.1%	35,2 k €	-61.3%	90,9 k €	-21.0%	115 k €	+48.3%	77,6 k €	+1143%	-7,4 k €	-111%	64,9 k €	-44.0%	116 k €	-4.6%	121,6 k €	+95.5%	62,2 k €
Net result	85,6 k €	-18.7%	105,3 k €	+18.0%	89,3 k €	+12517%	707,5 €	-94.4%	12,7 k €	-66.3%	37,6 k €	-15.2%	44,3 k €	-2.6%	45,5 k €	-6.4%	48,5 k €	+96.5%	24,7 k €	-21.4%	31,4 k €	+15.5%	27,2 k €	-73.3%	101,9 k €	+226%	-80,7 k €	-750%	-9,5 k €	-130%	31,5 k €	-44.0%	56,1 k €	+680%	7,2 k €
Balance sheet
Equity	343 k €	+3.2%	332,3 k €	+10.0%	302 k €	+14.9%	262,7 k €	+0.3%	262 k €	+29.8%	201,9 k €	+22.9%	164,3 k €	+36.9%	120,1 k €	+60.9%	74,6 k €	-6.8%	80,1 k €	-61.0%	205,4 k €	+18.1%	174 k €	+18.5%	146,8 k €	+227%	44,9 k €	-64.3%	125,6 k €	-7.0%	135,1 k €	+30.4%	103,6 k €	-1.0%	104,6 k €
Total assets	681,6 k €	+3.4%	659 k €	+25.4%	525,7 k €	+20.4%	436,7 k €	+10.5%	395 k €	-63.3%	1,1 M €	-13.3%	1,2 M €	-0.2%	1,2 M €	-7.7%	1,3 M €	-17.6%	1,6 M €	+29.3%	1,3 M €	-5.7%	1,3 M €	-8.3%	1,5 M €	-10.0%	1,6 M €	+38.9%	1,2 M €	-7.4%	1,3 M €	+18.3%	1,1 M €	-0.7%	1,1 M €
Cash	88,8 k €	-33.6%	133,8 k €	+61.8%	82,7 k €	-20.1%	103,5 k €	+19.3%	86,8 k €	-20.9%	109,7 k €	-25.4%	147,1 k €	+63.2%	90,1 k €	-11.2%	101,4 k €	-39.7%	168,1 k €	+119%	76,7 k €	-32.8%	114,1 k €	-15.7%	135,3 k €	+41.9%	95,3 k €	+39.7%	68,3 k €	-27.4%	94,1 k €	-34.1%	142,7 k €	-1.6%	145,1 k €
Debts	338,6 k €	+3.6%	326,7 k €	+46.1%	223,7 k €	+28.6%	173,9 k €	+30.8%	133 k €	-84.8%	872,5 k €	-18.7%	1,1 M €	-3.6%	1,1 M €	-12.0%	1,3 M €	-18.2%	1,5 M €	+47.1%	1,1 M €	-9.2%	1,2 M €	-11.8%	1,3 M €	-16.7%	1,6 M €	+51.4%	1 M €	-7.4%	1,1 M €	+16.9%	962 k €	-0.5%	966,3 k €
Other
Workforce	2,3 ETP	0.0%	2,3 ETP	+21.1%	1,9 ETP	-42.4%	3,3 ETP	0.0%	3,3 ETP	-37.7%	5,3 ETP	+1.9%	5,2 ETP	+8.3%	4,8 ETP	-23.8%	6,3 ETP	+16.7%	5,4 ETP	+31.7%	4,1 ETP	-45.3%	7,5 ETP	+114%	3,5 ETP	0.0%	3,5 ETP	-16.7%	4,2 ETP	+2.4%	4,1 ETP	+5.1%	3,9 ETP	+18.2%	3,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 13 ended

Active mandates

DERYA GEDERET

Director

Active

PHARMA OZ

Director · 0795.841.547

Represented by MEHMET OZ

Active

Ended mandates

Marc VAN AERSCHOT

Managing director · since 26 juin 2014 · until 25 juin 2020

Ended

Véronique VOS

Director · since 26 juin 2014 · until 25 juin 2020

Ended

Véronique VOS

Managing director · since 26 juin 2014 · until 25 juin 2020

Ended

MARC VAN AERSCHOT

Managing director · since 26 juin 2008 · until 26 juin 2014

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	09/07/2026	07/08/2025	13/06/2024	24/03/2023	07/07/2022	01/07/2021
General meeting	19/03/2026	20/03/2025	21/03/2024	16/03/2023	30/06/2022	24/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/03/2026	09/07/2026	French	PDF
Abridged model	31/12/2024	20/03/2025	07/08/2025	French	PDF
Abridged model	31/12/2023	21/03/2024	13/06/2024	French	PDF
Abridged model	31/12/2022	16/03/2023	24/03/2023	French	PDF
Abridged model	31/12/2021	30/06/2022	07/07/2022	French	PDF
Abridged model	31/12/2020	24/06/2021	01/07/2021	French	PDF
Abridged model	31/12/2019	28/02/2020	11/03/2020	French	PDF
Abridged model	31/12/2018	27/06/2019	28/06/2019	French	PDF
Abridged model	31/12/2017	28/06/2018	03/07/2018	French	PDF
Abridged model	31/12/2016	29/06/2017	30/06/2017	French	PDF
Abridged model	31/12/2015	30/06/2016	06/07/2016	French	PDF
Abridged model	31/12/2014	25/06/2015	29/06/2015	French	PDF
Abridged model	31/12/2013	26/06/2014	08/07/2014	French	PDF
Abridged model	31/12/2012	27/06/2013	31/08/2013	French	PDF
Abridged model	31/12/2011	28/06/2012	30/08/2012	French	PDF
Abridged model	31/12/2010	23/06/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	24/06/2010	31/08/2010	French	PDF
Abridged model	31/12/2008	25/06/2009	31/08/2009	French	PDF
Abridged model	31/12/2007	26/06/2008	04/08/2008	French	PDF
Abridged model	31/12/2006	28/06/2007	30/08/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 13 ended

Active mandates

DERYA GEDERET

Director

Active

PHARMA OZ

Director · 0795.841.547

Represented by MEHMET OZ

Active

Ended mandates

Marc VAN AERSCHOT

Managing director · since 26 juin 2014 · until 25 juin 2020

Ended

Véronique VOS

Director · since 26 juin 2014 · until 25 juin 2020

Ended

Véronique VOS

Managing director · since 26 juin 2014 · until 25 juin 2020

Ended

MARC VAN AERSCHOT

Managing director · since 26 juin 2008 · until 26 juin 2014

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/12/2024
DENOMINATION - DEMISSIONS, NOMINATIONS
PDF
Mandates19/04/2023
DEMISSIONS, NOMINATIONS
PDF
Restructuring20/07/2020
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring05/05/2020
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates29/07/2014
DEMISSIONS, NOMINATIONS
PDF
Capital / shares22/03/2012
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates05/09/2008
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202585,6 k €↓
2024
Annual accounts 2024105,3 k €↑
2024
Name changePHARM-OZ
2023
Annual accounts 202389,3 k €↑
2022
Annual accounts 2022707,5 €↓
2021
Annual accounts 202112,7 k €↓
2021
Name changeMAVEPHAR
2018
Annual accounts 201837,6 k €↓
2017
Annual accounts 201744,3 k €↓
2016
Annual accounts 201645,5 k €↓
2015
Annual accounts 201548,5 k €↑
2014
Annual accounts 201424,7 k €↓
2013
Annual accounts 201331,4 k €↑
2012
Annual accounts 201227,2 k €↓
2011
Annual accounts 2011101,9 k €↑
2010
Annual accounts 2010-80,7 k €↓
2009
Annual accounts 2009-9,5 k €↓
2008
Annual accounts 200831,5 k €↓
2007
Annual accounts 200756,1 k €↑
2006
Annual accounts 20067,2 k €
01/01/1968
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARM-OZ

Overview

What does PHARM-OZ do?

Trend over 18 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline